Does my hon. Friend agree that the fact that that drug is routinely available in France, Germany, Austria and Canada shows that our appraisal system is not working in this country.
Breast Cancer Drugs
Proceeding contribution from
Julie Elliott
(Labour)
in the House of Commons on Thursday, 26 January 2017.
It occurred during Backbench debate on Breast Cancer Drugs.
Type
Proceeding contribution
Reference
620 c509
Session
2016-17
Chamber / Committee
House of Commons chamber
Librarians' tools
Timestamp
2024-08-13 12:55:29 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2017-01-26/17012637000362
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2017-01-26/17012637000362
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2017-01-26/17012637000362